IE33123L - Vaccines - Google Patents

Vaccines

Info

Publication number
IE33123L
IE33123L IE72769A IE72769A IE33123L IE 33123 L IE33123 L IE 33123L IE 72769 A IE72769 A IE 72769A IE 72769 A IE72769 A IE 72769A IE 33123 L IE33123 L IE 33123L
Authority
IE
Ireland
Prior art keywords
antigen
vaccines
agglutinogenic
illness
bacteria
Prior art date
Application number
IE72769A
Other versions
IE33123B1 (en
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of IE33123L publication Critical patent/IE33123L/en
Publication of IE33123B1 publication Critical patent/IE33123B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1,248,097. Vaccines. INSTITUT MERIEUX. 27 May, 1969 [28 May, 1968], No. 26822/69. Heading A5B. Vaccines comprise a combination of an agglutinogenic antigen with sufficient of an immune serum to that antigen to saturate all the agglutinogenic sites of the antigen. Vaccines specified are effective against brucellosis, coli-bacillosis, salmonellosis, staphylococial illness, streptococcal illness, tuberculosis, whooping cough, cholera, plague, Newcastle disease and influenza. The antigen may consist of inactivated whole bacteria or attenuated live bacteria. [GB1248097A]
IE72769A 1968-05-28 1969-05-27 New vaccines and processes for their preparation IE33123B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU56161 1968-05-28

Publications (2)

Publication Number Publication Date
IE33123L true IE33123L (en) 1969-11-28
IE33123B1 IE33123B1 (en) 1974-03-20

Family

ID=19725613

Family Applications (1)

Application Number Title Priority Date Filing Date
IE72769A IE33123B1 (en) 1968-05-28 1969-05-27 New vaccines and processes for their preparation

Country Status (10)

Country Link
AT (1) AT293612B (en)
BE (1) BE733615A (en)
CH (1) CH513979A (en)
DE (1) DE1966436C3 (en)
FR (1) FR2009493A1 (en)
GB (1) GB1248097A (en)
IE (1) IE33123B1 (en)
IT (1) IT1053697B (en)
LU (1) LU56161A1 (en)
NL (1) NL6908122A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949031A1 (en) * 1978-12-15 1980-07-17 Sandoz Ag VACCINE
FR2527447A1 (en) * 1982-05-27 1983-12-02 Leguern Jacques Growth stimulating compsn for domestic animals - comprising vaccine mixed with sample of blood and injected by intramuscular route

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE231055C (en) *
DE231056C (en) *
GB150334A (en) * 1919-08-23 1921-06-30 Elektro Osmose Ag Manufacture of specific vaccines
GB708976A (en) * 1952-02-16 1954-05-12 Fort Dodge Lab Inc Vaccine and process for manufacturing the same

Also Published As

Publication number Publication date
IT1053697B (en) 1981-10-10
GB1248097A (en) 1971-09-29
DE1966436A1 (en) 1972-12-07
DE1966436B2 (en) 1981-01-22
AT293612B (en) 1971-10-25
LU56161A1 (en) 1970-01-14
CH513979A (en) 1971-10-15
BE733615A (en) 1969-11-27
FR2009493A1 (en) 1970-02-06
DE1966436C3 (en) 1982-02-04
DE1926817A1 (en) 1970-01-15
NL6908122A (en) 1969-12-02
IE33123B1 (en) 1974-03-20

Similar Documents

Publication Publication Date Title
CA956222A (en) Air-permeable laminate and the preparation thereof
SE398557B (en) MEASURE THAT BY ENZYME IMMUNO ANALYSIS PAVISA ANTIBODIES ANTIGENS OR HAPTENES
CA957760A (en) Ultrasonic inspection and diagnosis system
CA941966A (en) Merchandise handling and identifying system
CA969423A (en) Embossing and encoding system
HUP9801223A2 (en) Method for enhancing the antibody response to specific antigens with interleukin-10
CA949742A (en) Pipeline cleaner and sealer
IE33123L (en) Vaccines
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
DK76191D0 (en) FILAMENTOEST HAEMAGGLUTININ FROM B.PERTUSSIS
IT1043894B (en) DEAD VACCINE AGAINST RINITIS INFECTIVE ATRCFIC PIGS AND PROCEDURE FOR ITS PREPARATION
CA936095A (en) Rubella vaccine and method
CA958330A (en) Microbial pesticide and preparation thereof
IT7830643A0 (en) TYPHOUS VACCINE AND PROCEDURE FOR ITS PREPARATION.
SUH Studies on the Effects of Antibiotics to the Antigens of Shigella Flexneri
ATE346602T1 (en) BACTERIAL WALL FRACTIONS WITH ADJUVANT ACTIVITY
GB1234718A (en) Vaccines
CA926396A (en) 2,6-methano-3-benzazocines and preparation thereof
Murzewski et al. The probability distribution of residual microstresses in an elastic medium(Elastic medium residual microstresses probability distribution, noting microdistortion tensor linear and transverse components and tangential and normal stresses relation)
CA839228A (en) Vaccine and its preparation
DE69721498D1 (en) IMMUNOGENAL COMPLEX, ISCOM, FOR THE PRODUCTION OF A VACCINE FOR ADOLESCENTS
GB1155683A (en) New Polyvalent Immunizing Agents and Methods for their Production
IL38391A (en) 6-(3-alkoxyphenyl)-6-hydroxy-3-hexanones and their preparation
IT1025318B (en) 3.7 DIMETHYL 3 HYDROXY 6 OCTENITRI LE AND PROCEDURE FOR ITS PREPARATION
Gieser Problem in Kalinga morphophonemics